Nejstgaard, Camilla Hansen

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

Flemyng, E., Moore, T. H., Boutron, I., Higgins, J. P., Hróbjartsson, A., Nejstgaard, C. H., & Dwan, K. (2023) · BMJ Evidence-Based Medicine

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 264

An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials

Hopewell, S., Boutron, I., Chan, A.-W., Collins, G. S., de Beyer, J. A., Hróbjartsson, A., Nejstgaard, C. H., Østengaard, L., Schulz, K. F., Tunn, R., et al. (2022) · Nature Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 127

Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review

Nejstgaard, C. H., Bero, L., Hróbjartsson, A., Jørgensen, A. W., Jørgensen, K. J., Le, M., & Lundh, A. (2020) · BMJ

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 116

A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010

Nejstgaard, C. H., Boutron, I., Chan, A.-W., Chow, R., Hopewell, S., Masalkhi, M., Moher, D., Schulz, K. F., Shlobin, N. A., Østengaard, L., et al. (2023) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 21

Development of a topic‐specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010

Østengaard, L., Barrientos, A., Boutron, I., Chan, A., Collins, G., Hopewell, S., Moher, D., Nejstgaard, C. H., Schulz, K. F., Speich, B., et al. (2024) · Cochrane Evidence Synthesis and Methods

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 15